Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
430 JPY | +2.38% | +2.63% | -38.75% |
Mar. 19 | SanBio Eyes Approval for Brain Injury Treatment Drug SB623 By March | MT |
Mar. 19 | Jefferies Adjusts SanBio’s Price Target to 270 Yen From 310 Yen, Keeps at Underperform | MT |
Sales 2025 * | - | Sales 2026 * | 660M 4.31M | Capitalization | 29.51B 193M |
---|---|---|---|---|---|
Net income 2025 * | -3.3B -21.53M | Net income 2026 * | -3.53B -23.05M | EV / Sales 2025 * | - |
Net Debt 2025 * | 226M 1.48M | Net Debt 2026 * | 3.03B 19.83M | EV / Sales 2026 * | 49.3 x |
P/E ratio 2025 * |
-8.76
x | P/E ratio 2026 * |
-8.21
x | Employees | 29 |
Yield 2025 * |
-
| Yield 2026 * |
-
| Free-Float | 71.15% |
Latest transcript on SanBio Company Limited
1 day | +2.38% | ||
1 week | +2.63% | ||
Current month | +3.61% | ||
1 month | +9.69% | ||
3 months | -21.96% | ||
6 months | -5.70% | ||
Current year | -38.75% |
Managers | Title | Age | Since |
---|---|---|---|
Keita Mori
CEO | Chief Executive Officer | 56 | 13-02-26 |
Shinya Hirata
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Noboru Kotani
BRD | Director/Board Member | 67 | 13-02-28 |
Keita Mori
CEO | Chief Executive Officer | 56 | 13-02-26 |
Toru Kawanishi
CHM | Chairman | 56 | 13-02-26 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 2 M€ | -.--% | ||
0.01% | 7 M€ | -.--% | - | |
0.00% | 10 M€ | -3.35% | - | |
0.00% | 773 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-02 | 430 | +2.38% | 475,100 |
24-05-01 | 420 | +1.20% | 376,100 |
24-04-30 | 415 | -0.95% | 314,900 |
24-04-26 | 419 | +1.45% | 238,800 |
Delayed Quote Japan Exchange, May 02, 2024 at 02:00 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-38.75% | 193M | |
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+6.79% | 14.16B | |
+38.61% | 12.63B |
- Stock Market
- Equities
- 4592 Stock